Lung cancer in Mexico: Findings from the Global Burden of Disease Study, 1990-2016

Objective. To show lung cancer (LC) mortality and disability-adjusted life years (DALYs) in Mexico. Materials and methods. With the visualization tools at the Global Burden of Disease Study website, we analyzed LC mortality and disability-adjusted life years (DALYs) by state, sex, socio­demographic...

Full description

Bibliographic Details
Main Authors: Carlos Manuel Guerrero-López, Edson Serván-Mori, Roxana Rodríguez-Franco, Julio César Montañez-Hernández, Héctor Gómez-Dantés
Format: Article
Language:English
Published: Instituto Nacional de Salud Pública 2019-06-01
Series:Salud Pública de México
Subjects:
Online Access:http://www.saludpublica.mx/index.php/spm/article/view/9932
_version_ 1818333810788401152
author Carlos Manuel Guerrero-López
Edson Serván-Mori
Roxana Rodríguez-Franco
Julio César Montañez-Hernández
Héctor Gómez-Dantés
author_facet Carlos Manuel Guerrero-López
Edson Serván-Mori
Roxana Rodríguez-Franco
Julio César Montañez-Hernández
Héctor Gómez-Dantés
author_sort Carlos Manuel Guerrero-López
collection DOAJ
description Objective. To show lung cancer (LC) mortality and disability-adjusted life years (DALYs) in Mexico. Materials and methods. With the visualization tools at the Global Burden of Disease Study website, we analyzed LC mortality and disability-adjusted life years (DALYs) by state, sex, socio­demographic index (SDI), age, and risk factors between 1990 and 2016. Results. Mortality rate decreased from 13.9 to 9.1 per 100 000 between 1990 and 2016. This reduction is greater among men. However, deaths by LC rose from 5 478 to 8 470. DALYs rate also decreased. Northern states with higher SDI face a larger burden from LC but exhibited greater reductions compared with southern, less developed states. The burden of LC is concentrated among older population. Smoking is the main risk factor for LC. Conclusions. The burden by LC has decreased but is differential between states. LC threatens financially both the health system and individuals, since an important fraction of the population is not protected.
first_indexed 2024-12-13T13:57:33Z
format Article
id doaj.art-eea99ec942804fc7a32545f20e6c8c49
institution Directory Open Access Journal
issn 0036-3634
language English
last_indexed 2024-12-13T13:57:33Z
publishDate 2019-06-01
publisher Instituto Nacional de Salud Pública
record_format Article
series Salud Pública de México
spelling doaj.art-eea99ec942804fc7a32545f20e6c8c492022-12-21T23:42:50ZengInstituto Nacional de Salud PúblicaSalud Pública de México0036-36342019-06-01613, may-jun24024810.21149/993216663Lung cancer in Mexico: Findings from the Global Burden of Disease Study, 1990-2016Carlos Manuel Guerrero-López0Edson Serván-Mori1Roxana Rodríguez-Franco2Julio César Montañez-Hernández3Héctor Gómez-Dantés4Instituto Nacional de Salud Pública. Cuernavaca, Morelos, México.Investigador independiente. Cuernavaca, Morelos, México.Instituto Nacional de Salud Pública. Cuernavaca, Morelos, México.Instituto Nacional de Salud Pública. Cuernavaca, Morelos, México.Instituto Nacional de Salud Pública. Cuernavaca, Morelos, México.Objective. To show lung cancer (LC) mortality and disability-adjusted life years (DALYs) in Mexico. Materials and methods. With the visualization tools at the Global Burden of Disease Study website, we analyzed LC mortality and disability-adjusted life years (DALYs) by state, sex, socio­demographic index (SDI), age, and risk factors between 1990 and 2016. Results. Mortality rate decreased from 13.9 to 9.1 per 100 000 between 1990 and 2016. This reduction is greater among men. However, deaths by LC rose from 5 478 to 8 470. DALYs rate also decreased. Northern states with higher SDI face a larger burden from LC but exhibited greater reductions compared with southern, less developed states. The burden of LC is concentrated among older population. Smoking is the main risk factor for LC. Conclusions. The burden by LC has decreased but is differential between states. LC threatens financially both the health system and individuals, since an important fraction of the population is not protected.http://www.saludpublica.mx/index.php/spm/article/view/9932global burden of disease, méxico, lung cancer, dalys.
spellingShingle Carlos Manuel Guerrero-López
Edson Serván-Mori
Roxana Rodríguez-Franco
Julio César Montañez-Hernández
Héctor Gómez-Dantés
Lung cancer in Mexico: Findings from the Global Burden of Disease Study, 1990-2016
Salud Pública de México
global burden of disease, méxico, lung cancer, dalys.
title Lung cancer in Mexico: Findings from the Global Burden of Disease Study, 1990-2016
title_full Lung cancer in Mexico: Findings from the Global Burden of Disease Study, 1990-2016
title_fullStr Lung cancer in Mexico: Findings from the Global Burden of Disease Study, 1990-2016
title_full_unstemmed Lung cancer in Mexico: Findings from the Global Burden of Disease Study, 1990-2016
title_short Lung cancer in Mexico: Findings from the Global Burden of Disease Study, 1990-2016
title_sort lung cancer in mexico findings from the global burden of disease study 1990 2016
topic global burden of disease, méxico, lung cancer, dalys.
url http://www.saludpublica.mx/index.php/spm/article/view/9932
work_keys_str_mv AT carlosmanuelguerrerolopez lungcancerinmexicofindingsfromtheglobalburdenofdiseasestudy19902016
AT edsonservanmori lungcancerinmexicofindingsfromtheglobalburdenofdiseasestudy19902016
AT roxanarodriguezfranco lungcancerinmexicofindingsfromtheglobalburdenofdiseasestudy19902016
AT juliocesarmontanezhernandez lungcancerinmexicofindingsfromtheglobalburdenofdiseasestudy19902016
AT hectorgomezdantes lungcancerinmexicofindingsfromtheglobalburdenofdiseasestudy19902016